Start Date
September 30, 2012
Primary Completion Date
Study Completion Date
March 31, 2013
GSK573719
Novel Dry-Powder Inhaler
GSK573719matched-placebo
Lead Sponsor
GlaxoSmithKline
INDUSTRY